Telomere length predicts progression and overall survival in chronic lymphocytic leukemia: data from the UK LRF CLL4 trial.
about
Identifying High-Risk Chronic Lymphocytic Leukemia: A Pathogenesis-Oriented Appraisal of Prognostic and Predictive Factors in Patients Treated with Chemotherapy with or without ImmunotherapyTelomere status in chronic lymphocytic leukemia with TP53 disruption.Longitudinal copy number, whole exome and targeted deep sequencing of 'good risk' IGHV-mutated CLL patients with progressive diseaseThe morphology of CLL revisited: the clinical significance of prolymphocytes and correlations with prognostic/molecular markers in the LRF CLL4 trial.Non-coding NOTCH1 mutations in chronic lymphocytic leukemia; their clinical impact in the UK CLL4 trial.Stop pulling my strings - what telomeres taught us about the DNA damage response.Telomere erosion in NF1 tumorigenesis.Chronic lymphocytic leukemia and small lymphocytic lymphoma: two faces of the same disease.ATM mutations in major stereotyped subsets of chronic lymphocytic leukemia: enrichment in subset #2 is associated with markedly short telomeres.Evolutionary ecology of telomeres: a review.Telomeres and Telomerase in Hematopoietic Dysfunction: Prognostic Implications and Pharmacological Interventions.Telomere length in poor-risk chronic lymphocytic leukemia: associations with disease characteristics and outcome.Telomere Length Dynamics and the Evolution of Cancer Genome Architecture.Telomeres and genomic evolution.
P2860
Q28077136-CD36833A-AB72-4663-9123-463D3F4C7CCDQ36093789-D86A6AEC-A4C4-4453-B9DC-64352A28D236Q36884141-32903568-1BB1-4FB0-AE62-D62597F5403AQ37199470-CBE2D61F-F310-4A05-9096-D140668A69CBQ37621653-E3F8CB71-6983-4556-BF77-9C54D7296F7AQ37742751-87C00C89-807A-4CBB-88A7-05E380AF7254Q38814214-FDB6414B-A7BF-428F-8D2B-CAB878C6E0B0Q39034465-8909C8E2-8506-449E-9C88-71E4C59B56CEQ42384352-3F122B2B-E3F5-4052-B690-EAEB0B10B10CQ46293068-099AB970-2115-4A57-A55D-6CC3ED4360C1Q47612537-79BEFCCD-9920-489F-9470-5433121DB8B6Q50074751-DB9316AA-C8AD-43C4-9219-2448621758E3Q50131917-A34686F3-0855-4F4B-88CC-2AC92C833706Q52687715-AD99111A-9216-4B67-823F-76B20CF29D40
P2860
Telomere length predicts progression and overall survival in chronic lymphocytic leukemia: data from the UK LRF CLL4 trial.
description
2015 nî lūn-bûn
@nan
2015 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Telomere length predicts progr ...... ta from the UK LRF CLL4 trial.
@ast
Telomere length predicts progr ...... ta from the UK LRF CLL4 trial.
@en
type
label
Telomere length predicts progr ...... ta from the UK LRF CLL4 trial.
@ast
Telomere length predicts progr ...... ta from the UK LRF CLL4 trial.
@en
prefLabel
Telomere length predicts progr ...... ta from the UK LRF CLL4 trial.
@ast
Telomere length predicts progr ...... ta from the UK LRF CLL4 trial.
@en
P2093
P2860
P50
P356
P1433
P1476
Telomere length predicts progr ...... ata from the UK LRF CLL4 trial
@en
P2093
A Gardiner
A J Steele
D Catovsky
D G Oscier
D Gonzalez de Castro
J C Strefford
P2860
P2888
P304
P356
10.1038/LEU.2015.217
P577
2015-08-10T00:00:00Z
P5875
P6179
1022470652